Ihtsham Haq, MD
Ihtsham Haq MD received his BS in Biomedical Engineering and BA in Philosophy from Columbia University, and his MD from the State University of New York at Brooklyn. Dr. Haq completed his Neurology residency at Georgetown University. Following his residency he completed a 3-‐ year Movement Disorders fellowship at the University of Florida, one of the world’s leading centers for movement disorder surgery. During his time at UFL his training included the medical and surgical treatment of movement disorders, including microelectrode recording for Deep Brain Stimulation (DBS) surgery. Dr. Haq has been on faculty at Wake Forest School of Medicine since 2009 and treats patients with a variety of movement disorders, including Parkinson’s disease, essential tremor, dystonia, and Tourette syndrome. His twin research interests are the nonmotor functions of the basal ganglia and ways to use technology to define risk factors for disease. These efforts have included bringing DBS for Tourette's and OCD to Wake Forest, as well as collaborating with others to measure dopamine levels in awake patients to study impulsivity, basal ganglia energy metabolism diseases, and to develop new DBS devices. On the technology side, he works to make Electronic Medical Records research, patient, and physician friendly as a member of the Epic Neurosciences Steering Committee and the Chicago Based Neurology Practice Based Research Network. He is also active in trials of a wearable device that tracks Parkinson's patients' symptoms, and a program that will automatically calculate best DBS settings.
Association between subthalamic nucleus deep brain stimulation and weight gain: results of a case-control study. Strowd RE, Herco M, Passmore-Griffin L, Avery B, Haq I, Tatter SB, Tate J, Siddiqui MS.. Clin Neurol Neurosurg. 2016;140():38-42.
Tractography activation patterns in dorsolateral prefrontal cortex suggest better clinical responses in OCD DBS. Hartmann CJ, Lujan JL, Chaturvedi A, Goodman WK, Okun MS, McIntyre CC, Haq IU.. Front Neurosci. 2016;9():519.
Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson's disease: a quantitative study. Vallabhajosula S, Haq IU, Hwynn N, Oyama G, Okun M, Tillman MD, Hass CJ.. Brain Stimul. 2015;8(1):64-75.
Person-centered care in the home setting for Parkinson's disease: operation house call quality of care pilot study. Hack N, Akbar U, Monari EH, Eilers A, Thompson-Avila A, Hwynn NH, Sriram A, Haq I, Hardwick A, Malaty IA, Okun MS.. Parkinsons Dis. 2015;2015():639494.
Smile without euphoria induced by deep brain stimulation: a case report. Morishita T, Foote KD, Archer DB, Coombes SA, Vaillancourt DE, Hassan A, Haq IU, Wolf J, Okun MS.. Neurocase. 2015;21(6):674-678.
Cognitive impairment in rapid-onset dystonia-parkinsonism. Cook JF, Hill DF, Snively BM, Boggs N, Suerken CK, Haq I, Stacy M, McCall WV, Ozelius LJ, Sweadner KJ, Brashear A.. Mov Disord. 2014;29(Suppl 3):344-350.
Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings. Oblak AL, Hagen MC, Sweadner KJ, Haq I, Whitlow CT, Maldjian JA, Epperson F, Cook JF, Stacy M, Murrell JR, Ozelius LJ, Brashear A, Ghetti B.. Acta Neuropathol. 2014;128(1):81-98
Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor. Thompson AJ, Peng-Chen Z, Pastrana M, Foote KD, Haq I, Okun MS.. Neurocase. 2014;20(6):698-703.
Rapid-onset dystonia-Parkinsonism presenting as tremor-dominant Parkinson's disease (PO4.161) [abstract]. Tate J, Brashear A, Whitlow C, Snively B, Ozelius L, Sweadner K, Stacy M, Haq I.. Neurology. 2013;80(1 Meeting Abstracts):P04.
An unusual aetiology for internuclear ophthalmoplegia. Vishwas MS, Whitlow CT, Ihtsham ul Haq.. BMJ Case Rep. 2013;2013():.
Diagnostic challenges in movement disorders: Sensory Ataxia Neuropathy Dysarthria and Ophthalmoplegia (SANDO) syndrome. Lovan A, Haq IU, Balakrishnan N.. BMJ Case Rep. 2013;2013():.
Selective use of low frequency stimulation in Parkinson's disease based on absence of tremor. Stegemoller EL, Vallabhajosula S, Haq I, Hwynn N, Hass CJ, Okun MS.. NeuroRehabilitation. 2013;33(2):305-312.
Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. Haq IU, Foote KD, Goodman WG, Wu SS, Sudhyadhom A, Ricciuti N, Siddiqui MS, Bowers D, Jacobson CE, Ward H, et al.. Neuroimage. 2011;54(Suppl 1):S247-S255.
Deep brain stimulation in movement disorders. Siddiqui MS, Haq, Iu, Okun MS.. Continuum (Minneapolis, Minn.). 2010;16(1):110-130.The number and nature of emergency department encounters in patients with deep brain stimulators. Resnick AS, Foote KD, Rodriguez RL, Malaty IA, Moll JL, Carden DL, Krock NE, Medley MM, Burdick A, Haq IU, et al.. J Neurol. 2010;257(1):122-131.
Clonazepam and botulinum toxin for the treatment of alien limb phenomenon. Haq IU, Malaty IA, Okun MS, Jacobson CE, Fernandez HH, Rodriguez RR.. Neurologist. 2010;16(2):106-108.
Should we consider Vim thalamic deep brain stimulation for select cases of severe refractory dystonic tremor. Morishita T, Foote KD, Haq IU, Zeilman P, Jacobson CE, Okun MS.. Stereotact Funct Neurosurg. 2010;88(2):98-104.
An evaluation of rating scales utilized for deep brain stimulation for dystonia. Susatia F, Malaty IA, Foote KD, Wu SS, Zeilman PR, Mishra M, Rodriguez RL, Haq IU, Jacobson CE IV, Sun A, et al.. J Neurol. 2010;257(1):44-58.
Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder. Burdick A, Foote KD, Goodman W, Ward HE, Ricciuti N, Murphy T, Haq I, Okun MS.. Neurocase. 2010;16(4):321-330.
A case of mania following deep brain stimulation for obsessive compulsive disorder. Haq IU, Foote KD, Goodman WK, Ricciuti N, Ward H, Sudhyadhom A, Jacobson CE, Siddiqui MS, Okun MS.. Stereotact Funct Neurosurg. 2010;88(5):322-328.
Prevalence of twiddler's syndrome as a cause of deep brain stimulation hardware failure. Burdick AP, Okun MS, Haq IU, Ward HE, Bova F, Jacobson CE, Bowers D, Zeilman P, Foote KD.. Stereotact Funct Neurosurg. 2010;88(6):353-359.
A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: the Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR). Sudhyadhom A, Haq IU, Foote KD, Okun MS, Bova FJ.. Neuroimage. 2009;47(Suppl 2):T44-T52.
De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report. Servello D, Sassi M, Brambilla A, Porta M, Haq I, Foote KD, Okun MS.. J Neurol. 2009;256(9):1533-1539.